Shanghai Pharmaceuticals Holding
E-mail: pharm@sphchina.com
| Type | listed |
|---|---|
| Traded as | SSE: 601607 SEHK: 2607 |
| Industry | Pharmaceuticals |
| Founded | 1994 |
| Headquarters | Shanghai, China |
| Area served | Asia-Pacific, China |
| Revenue |  ¥187 billion yuan RMB, As of 2019 |
| Website | www.sphchina.com |
Shanghai Pharmaceuticals Holding Co. Ltd. (“SPH”) is a vertically-integrated and diversified pharmaceutical group. The company has dual listings on the stock exchanges in Shanghai (601607) and Hong Kong (02067) respectively. The company provides leading healthcare services in: Research & Development, Manufacturing, Distribution and Retail.
For detailed contact information visit location pages below.
Shanghai Pharmaceuticals Holding's locations around the world
Clinical Trials sponsored by Shanghai Pharmaceuticals Holding
-
Shanghai Pharmaceuticals Holding Co., LtdWervingNMO-spectrumstoornisChina
-
Shanghai Pharmaceuticals Holding Co., LtdVoltooidGeavanceerde vaste tumorChina
-
Shanghai Pharmaceuticals Holding Co., LtdVoltooidHER2-positieve borstkankerChina
-
Shanghai Pharmaceuticals Holding Co., LtdVoltooid
-
Shanghai Pharmaceuticals Holding Co., LtdWervingGeavanceerde solide tumorenChina
-
Shanghai Pharmaceuticals Holding Co., LtdWervingLokaal gevorderde of uitgezaaide borstkankerChina
-
Shanghai Pharmaceuticals Holding Co., LtdWerving
-
Shanghai Pharmaceuticals Holding Co., LtdWerving
-
Shanghai Pharmaceuticals Holding Co., LtdActief, niet wervendGeavanceerde solide tumorenChina
-
Shanghai Pharmaceuticals Holding Co., LtdVoltooidChronische Abnormale Immuunactivatie bij HIV/AIDSChina